Medication info

Amplejine Met Tablet 5/1000 milligrams (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Dongkook Pharmaceutical Co., Ltd.
Appearance
Brownish-yellow, double-sided convex film-coated tablet
Packaging
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 60 tablets/bottle
Approval status
Active

MFDS item code 202201445 · Approved 2022.04.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component, empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this drug is coadministered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). This drug should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this drug is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function decreases to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Drug, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Dongkook Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

View approved original text

This medication is used to complement diet and exercise therapy to aid blood sugar control in adults with type 2 diabetes. It is particularly effective in patients whose blood sugar is not adequately controlled, and caution is required for patients with established cardiovascular disease. This medication helps improve blood sugar levels and aids in diabetes management.

How to take

Adult dose

The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component, empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this drug is coadministered with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). This drug should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this drug is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function decreases to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Drug, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication may cause a rare but serious side effect called severe lactic acidosis, so caution is necessary. When taking this medication with other diabetes drugs such as insulin or sulfonylureas, the risk of hypoglycemia may increase, so care should be taken. This medication should not be used in certain patients with moderate to severe renal impairment, acute kidney problems, severe infections, or heart failure. When undergoing tests using iodinated contrast materials, this medication must be discontinued before and after the examination due to the risk of renal damage and lactic acidosis, and should be resumed only after normal kidney function is confirmed. Patients who are at risk of decreased fluid volume, such as those who are dehydrated due to vomiting or diarrhea, should be cautious when taking this medication and may need to temporarily discontinue it. This medication may increase the risk of urinary and genital infections, so any signs of infection should be reported to a healthcare professional immediately. Hypoglycemic symptoms may occur during treatment, so if symptoms such as dizziness, cold sweat, or severe fatigue appear, blood sugar levels should be checked, and appropriate measures should be taken. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication and should consider alternative treatment options if necessary. Elderly patients are at higher risk of renal function decline, so regular kidney function monitoring is required, and maximum dosage should be avoided while considering proper dosage adjustments. It is advisable to avoid alcohol intake during the use of this medication, as alcohol may increase the risk of lactic acidosis. Additionally, this medication may reduce vitamin B12 levels, so periodic monitoring of vitamin B12 levels is recommended for long-term use. If surgery is planned, this medication should be discontinued 48 hours prior to the surgery and resumed only after normal kidney function has been confirmed post-surgery. In cases of overdose, serious side effects such as hypoglycemia or lactic acidosis may occur, and immediate medical treatment should be sought. Caution is needed when driving or operating machinery while on this medication, and activities should be restrained if symptoms such as dizziness or drowsiness occur. Patients taking this medication should regularly check their blood sugar levels, kidney function, electrolyte levels, etc., and consult with healthcare professionals if any abnormal signs occur.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 277 more
  • abnormal liver function tests
  • hepatitis
  • dysgeusia
  • itching
  • rash
  • urticaria
  • erythema multiforme
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • perineal necrosis
  • vulvovaginal candidiasis
  • vulvitis
  • balanitic inflammation
  • pyelonephritis
  • urosepsis
  • headache
  • dizziness
  • cerebral infarction
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • weakness
  • chest discomfort
  • chest pain
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • angina
  • myocardial infarction
  • unstable angina
  • insomnia
  • anxiety
  • weight loss
  • weight gain
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • diabetic foot
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • urinary stones
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urine
  • cervical inflammation
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • pathological myopia
  • retinal detachment
  • retinal drusen
  • retinal vein occlusion
  • retinal tear with detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • ear pain
  • postural dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic bleeding
  • soft tissue infection
  • pneumonia
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • nasopharyngitis
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • tinea corporis
  • dental abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • positional vertigo
  • sensory loss
  • dysesthesia
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • intracranial aneurysm
  • memory impairment
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disturbances
  • drowsiness
  • CNS-origin dizziness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • fever
  • facial swelling
  • chills
  • peculiar sensation
  • edema
  • pain
  • pain at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • chest pain
  • fatigue
  • peripheral swelling
  • facial swelling
  • edema
  • epigastric pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • rectal bleeding
  • chronic gastritis
  • ischemic colitis
  • enteritis
  • flatulence
  • gastric polyp
  • gingival swelling
  • passage of bloody stools
  • hemorrhoids
  • colonic bleeding
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • abdominal pain
  • gastritis
  • gastrointestinal disorders
  • upper respiratory infection
  • bronchitis
  • soft tissue infection
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • appendiceal abscess
  • appendicitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tinea corporis
  • dental abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • nasopharyngitis
  • upper respiratory infection
  • periodontitis
  • dental abscess
  • headache
  • positional dizziness
  • facial paralysis
  • drowsiness
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • ligament injury
  • ligament sprain
  • arthralgia
  • low back pain
  • musculoskeletal pain
  • osteoporosis
  • low back pain
  • limb pain
  • musculoskeletal chest pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • retinal tear with detachment
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • cholesteatoma
  • gastric cancer
  • leiomyoma
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • ear pain
  • postural dizziness
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius to preserve the medication's efficacy over time.

Appearance and packaging

Appearance

Brownish-yellow, double-sided convex film-coated tablet

Package unit

10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.